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Membrane anchorVenom of Lachesana tarabaevi (Zodariidae, “ant spiders”) exhibits high insect toxicity and serves a rich source
of potential insecticides. Five new peptide toxins active against insects were isolated from the venom by
means of liquid chromatography and named latartoxins (LtTx). Complete amino acid sequences of LtTx
(60-71 residues) were established by a combination of Edman degradation, mass spectrometry and selective
proteolysis. Three toxins have eight cysteine residues that form four intramolecular disulﬁde bridges, and
two other molecules contain an additional cystine; three LtTx are C-terminally amidated. Latartoxins can
be allocated to two groups with members similar to CSTX and LSTX toxins from Cupiennius salei (Ctenidae)
and Lycosa singoriensis (Lycosidae). The interesting feature of the new toxins is their modular organization:
they contain an N-terminal cysteine-rich (knottin or ICK) region as in many neurotoxins from spider venoms
and a C-terminal linear part alike some cytolytic peptides. The C-terminal fragment of one of the most abun-
dant toxins LtTx-1a was synthesized and shown to possess membrane-binding activity. It was found to assume
amphipathic α-helical conformation in membrane-mimicking environment and exert antimicrobial activity at
micromolar concentrations. The tails endow latartoxins with the ability to bind and damage membranes; LtTx
show cytolytic activity in ﬂy larvae neuromuscular preparations. We suggest a membrane-dependent mode of
action for latartoxins with their C-terminal linear modules acting as anchoring devices.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Venomous animals are widespread in the world, inhabiting a large
number of natural areas and climatic zones. These animals can efﬁ-
ciently paralyze and kill prey or defend themselves from aggressors
using their remarkable weapon — venom. Two main strategies of
venom composition formation have probably arisen in the course of
evolution: the ﬁrst is based on usage of a limited number of active
compounds with wide spectrum of activity, and the second implies
production of a vast diversity of rather selective components. Special
place among venomous animals belongs to spiders that reach incred-
ible success in venom production and seem to adhere to the latter
strategy [1,2]. Spider venoms are a rich source of diverse biologicallycyto-insectotoxins; DOPE, 1,2-
dioleoyl-sn-glycero-3-phospho-
EST, expressed sequence tag;
not; LD50, median lethal dose;
concentration; PQM, processing
istry, Russian Academy of Sci-
n Federation. Tel.: +7 495 336
l rights reserved.active substances, from low-molecular-weight compounds to multi-
domain proteins. Disulﬁde-rich peptide toxins (b10 kDa) are the
major component of most spider venoms. In the venom of some spe-
cies, however, other predominant components may be found, such as
enzymes (sphingomyelinases D in recluse spiders [3]), protein neuro-
toxins (latrotoxins in black widows [4]), linear cytolytic peptides
(cyto-insectotoxins (CITs) in the zodariid Lachesana tarabaevi [5]) or
acylpolyamines (argiopin, argiopinins and pseudoargiopinins in the
web-weaver Argiope lobata [6]). Most of disulﬁde-rich peptides form
the inhibitor cystine knot (ICK) fold and are active on ion channels
and ionotropic receptors of plasma membranes. As opposed to
disulﬁde-rich toxins, linear peptides typically exhibit cytolytic activi-
ty through the ability to bind to and damage lipid bilayers [7]. Only a
few spider venoms have been studied into detail because of biological
material shortage. However, puriﬁcation and investigation of individ-
ual components of spider venoms is of high fundamental interest and
may have practical value [8]. In this work we investigated ﬁve new
peptides from L. tarabaevi spider venom that feature insect toxicity.
These peptides combine traits of two groups of spider venom constit-
uents. Their N-terminal part is disulﬁde-rich and features the conven-
tional ICK signature. They also contain an extended C-terminal tail
that seems to share its structural and functional properties with linear
cytolytic (antimicrobial) peptides (AMPs). Similar organization is
noted in case of some toxins produced by spiders from the Lycosoidea
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modules seems to have been proven efﬁcient and taken up by evolu-
tion in different spider families.
2. Materials and methods
Our detailed protocols on spider venom separation, toxin puriﬁca-
tion, sequencing and characterization can be found elsewhere [9].
2.1. Peptide puriﬁcation
Venomof L. tarabaevi (2 mgof freeze-dried powder)was dissolved in
150 μl of deionized water and fractionated using size-exclusion chroma-
tography on a TSK 2000SW column (7.5×600 mm, 12.5 nm pore size,
10 μm particle size; Toyo Soda Manufacturing Co., Tokyo, Japan). The el-
uent contained 10% acetonitrile in 0.1% aqueous triﬂuoroacetic acid
(TFA), and the ﬂow rate was 0.5 ml/min. Efﬂuent absorbance was mon-
itored at 210 nm. Active fractionswere separated by reverse-phaseHPLC
on a Vydac 218TP54 C18 column (4.6×250 mm, 30 nm pore size, 5 μm
particle size; Separations Group) using a 90-min linear gradient of aceto-
nitrile concentration (0–60%) in 0.1% TFA at a ﬂow rate of 0.7 ml/min.
Absorbance was monitored at 210 and 280 nm. The ﬁnal stage of active
components puriﬁcation was performed on the same Vydac column
using a 90-min linear gradient of solvent containing 50% acetonitrile
and 20% isopropanol in 0.1% TFA.
2.2. Mass spectrometry
Molecular mass measurements were carried out on a M@LDI-LR
mass spectrometer (Micromass) as described [5]. 2,5-Dihydroxy benzoic
acid was used as matrix (10 mg/ml in 70% acetonitrile, 0.1% TFA). Cali-
bration was performed using the ProteoMass peptide and protein cali-
bration kit with (mass range of 700–66000 Da; Sigma-Aldrich). For
data processing the MassLynx program package (Waters) was used.
2.3. Reduction of disulﬁde bonds and modiﬁcation of thiol groups
All procedureswere carried out as described [9]. Brieﬂy, freeze-dried
samples were dissolved in 50 μl of solution containing 6 M guanidine
hydrochloride, 3 mM EDTA, 0.5 M Tris–HCl (pH 8.5). A 100-fold excess
of 1,4-dithiothreitol was then added, and the samples were incubated
for 4 h at 40 °C. Then 4-vinylpyridine was added to the samples with
3-fold excess with respect to dithiothreitol, and the samples were incu-
bated for 15 min at room temperature in the dark. Modiﬁed polypep-
tides were separated by reverse-phase HPLC on a Jupiter C5 column
(2.0×150 mm, 30 nm pore size, 5 μm particle size; Phenomenex)
using a 60-min linear gradient of acetonitrile concentration (10–70%)
in 0.1% TFA at a ﬂow rate of 0.3 ml/min.
2.4. Protein sequencing
N-terminal amino acid sequences of the modiﬁed peptides were
determined by automatic Edman degradation using a Procise Model
492 protein sequencer (Applied Biosystems) according to
manufacturer's guidelines.
2.5. Selective proteolysis
Selective proteolysis at different amino acid residues was used to
determine full polypeptide sequences. Procedures described in [9]
were generally followed.
2.5.1. Endoproteinase Glu-C digestion
Digestion of 1 nmol of pure alkylated peptide was performed with
0.2 μg of endoproteinase Glu-C (Sigma-Aldrich) in 20 μl of 50 mM
ammonium bicarbonate buffer (pH 8.0). Probes were incubated for4 h at 37 °C. Peptide fragments were separated on a Luna C18 column
(3.0×150 mm, 30 nm pore size, 5 μm particle size; Phenomenex). A
60-min linear gradient of acetonitrile (0–60%) in 0.1% TFA at a ﬂow
rate of 0.5 ml/min was used.
2.5.2. Endoproteinase Asp-N digestion
1 nmol of pure alkylated peptide was dissolved in 50 μl of 50 mM
Tris–HCl (pH 8.0), and 0.2 μg of endoproteinase Asp-N (Sigma-Aldrich)
were added. Probes were incubated for 4 h at 37 °C. Peptide fragments
were separated on a Luna C18 column as described above.
2.5.3. CNBr cleavage
1 nmol of pure alkylated peptide was dissolved in 20 μl of 80%
aqueous TFA, and 1 μl of 5 M CNBr in acetonitrile (Sigma-Aldrich)
was added. The samples were incubated for 24 h at room tempera-
ture in the dark. The reaction was terminated by diluting the mixture
with 1 ml of cool distilled water, and the samples were dried using a
vacuum evaporator. Reaction products were separated on a Luna C18
column.
2.5.4. Cleavage at Asp-Pro bonds
1 nmol of pure alkylated peptide was dissolved in 98 μl of distilled
water, and 2 μl of 1 M HCl were added. The samples were incubated
for 30 min at 100 °C in a boiling water bath, and then the peptide
fragments were separated on a Luna C18 column.
2.6. Peptide synthesis
The C-terminal fragment of LtTx-1a (LtTx-1a C) was synthesized
on a peptide synthesizer Syro I (MultiSynTech) using the Fmoc/
t-butyl chemistry following a described procedure [10]. The purity
of the synthetic peptide was veriﬁed by reverse-phase HPLC and
MALDI MS.
2.7. cDNA library construction, sequencing, and analysis
All stages of cDNA library construction were completed in collab-
oration with DuPont Agriculture and Nutrition as described [11]. The
obtained sequences were compared using ClustalW2 (http://www.
ebi.ac.uk/Tools/msa/clustalw2/). The most abundant cDNA sequences
were translated to polypeptide sequences. The data were matched
with results of Edman sequencing of the native peptides.
2.8. CD
LtTx-1a and LtTx-1a C were dissolved at a concentration of 1 mg/ml
in: 110 mMNaCl, 50 mMNa2HPO4/NaH2PO4 (pH 7.5); 25 mM SDS. CD
spectra were recorded using a J-810 spectropolarimeter (Jasco, Japan)
as described previously [5]. Secondary structure content was analyzed
with the CONTINLL program [12].
2.9. Preparation of GUVs and LUVs
Dry 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and
1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DOPG) (both lipids
from Avanti Polar Lipids) were dissolved in chloroform/methanol mix-
ture (2:1, v/v). DOPE/DOPG ratio was 7:3 (w/w). Samples were dried
using a vacuum evaporator. Lipid ﬁlms were lyophilized for 5 h and
then suspended in aqueous solution containing 110 mM NaCl, 50 mM
Na2HPO4/NaH2PO4 (pH 7.5), the resulting lipid concentration was
10 mM. Samples were subjected to ultrasonication for 15 min and ex-
truded through a Whatman 1000 nm-pore-size polycarbonate mem-
brane (30 times at 25 °C) using a Mini-Extruder (Avanti Polar Lipids)
for giant unilamellar vesicles (GUVs) preparation. GUVs suspension
was then extruded through a Whatman 100 nm-pore-size polycarbon-
ate membrane for large unilamellar vesicles (LUVs) formation.
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The interaction of full-length native LtTx-1a and synthetic LtTx-1a
C with DOPG/DOPE GUVs was probed by the spin-down assay.
Latarcin 2a (Ltc 2a) and purotoxin 1 (PT1) served as positive and neg-
ative control, respectively. Each peptide (1–10 nmol) was dissolved
in 30 μl of 110 mM NaCl, 50 mM Na2HPO4/NaH2PO4 (pH 7.5). The
samples were then divided into two parts: 150 μl of phosphate buffer
were added to one part, and 150 μl of DOPG/DOPE GUVs suspension
(5 mM lipid concentration) were added to the other. Samples were
incubated for 1 h at 37 °C with constant stirring and centrifuged
(45 min, 16000 g). To determine the peptide concentration
remaining in the aqueous phase, all probes were assessed by
reverse-phase HPLC on a Jupiter C5 column (4.6×250 mm, 30 nm
pore size, 5 μm particle size; Phenomenex).
2.11. Insecticidal assays
Crude venom, puriﬁed toxins, and the synthetic peptide were tested
on ﬂesh ﬂy (Sarcophaga carnaria) larvae and house crickets (Acheta
domestica). Samples were dissolved in physiological saline (140 mM
NaCl, 5 mM KCl, 5 mM CaCl2, 1 mM MgCl2, 4 mM NaHCO3, and 5 mM
HEPES, pH 7.2), and a volume of 2 μl was injected into the fourth seg-
ment of larva or cricket's abdomen. Groups of 5 individuals were used
for every assayed concentration. Control animals got pure saline. Para-
lytic and lethal effects were observed during 24 h after injection.
2.12. Antimicrobial assays
Puriﬁed toxins and the synthetic peptide were tested on bacteria
(Arthrobacter globiformis VKM Ac-1112, Bacillus subtilis VKM B-501,
Escherichia coli DH5α, and Pseudomonas aeruginosa PAO1) following
the previously described modiﬁcation of the microtitre broth dilution
method [9]. Minimal inhibitory concentrations (MICs) are expressed
as the lowest concentration of peptide that caused 100% bacteria
growth inhibition.
2.13. Electrophysiology
Measurements were performed on Calliphora vicina ﬂy larvae neu-
romuscular preparations essentially as described [13]. The prepara-
tion was perfused with solution containing 172 mM NaCl, 2.5 mM
KCl, 0.5 mM CaCl2, 8 mM MgCl2, 5 mM HEPES, pH 7.2, and 52 mM
sucrose. Evoked excitatory postsynaptic current (EPSC) and sponta-
neous EPSC were recorded by a conventional two-electrode voltageFig. 1. Isolation of latartoxins. (A) Crude L. tarabaevi venom separation (size-exclusion chrom
reverse-phase HPLC on a Vydac C18 column in a linear gradient of acetonitrile. The active frclamp using glass microelectrodes. The input resistance of the muscle
cell membrane was estimated by measuring the response to a 10-mV
hyperpolarization step from the basic voltage of −80 mV.
3. Results
3.1. Venom separation and identiﬁcation of novel toxins
Following our usual strategy [9], the crude venom of L. tarabaeviwas
ﬁrst fractionated using size-exclusion chromatography, and its compo-
nents were separated to three broad fractions (I–III; see Fig. 1A). High
insect toxicity was detected in fraction II. To isolate individual active
components, this fraction was subjected to further separation by
reverse-phase HPLC (Fig. 1B). Previously, we reported on the cyto-
insectotoxins (CITs) that show equally potent insecticidal and antimi-
crobial activities [5]. Due to their amphipathic nature, CITs elute late
from a C18 column (after 50 min in Fig. 1B).We also detected insecticid-
al activity in fractions eluting earlier (at 40–50 min). These new active
polypeptide compounds with paralytic and lethal effects against insects
were further puriﬁed to homogeneity by still another round of reverse-
phase HPLC. All individual compounds were analyzed by MALDI MS
(Table 1). In result, ﬁve novel toxins were isolated from L. tarabaevi
venom and named latartoxins (LtTx-1a, 1b, 2a, 2b and 2c).
3.2. Latartoxin sequencing
Alkylation of non-reduced LtTx with 4-vinylpyridine revealed no
free thiol groups in the native peptides as detected by MS analysis.
Differences between the masses of native and reduced-alkylated pep-
tides, however, indicated that LtTx-1a, 1b and 2c contain eight
half-cystine residues, while LtTx-2a and 2b bear one additional disul-
ﬁde bridge.
The puriﬁed LtTx were completely sequenced using a combination
of Edman degradation, MS and site-speciﬁc proteolysis (Fig. 2) [9].
Brieﬂy, direct Edman degradation provided partial N-terminal se-
quences of 39 amino acid residues. LtTx-1a and 1b were then hydro-
lyzed at glutamic acid residues with endoproteinase Glu-C, and
LtTx-2c was digested at aspartic acid residues with endoproteinase
Asp-N. In the case of LtTx-2a and 2b nonenzymatic fragmentation of
polypeptide chains was performed at the Asp-Pro bonds by mild acid
hydrolysis on the ﬁrst step, and at methionine residues by CNBr on
the second step. All fragments were separated using reverse-phase
HPLC and identiﬁed by MALDI MS. Puriﬁed fragments with unknown
sequences were subjected to Edman degradation and full peptide pri-
mary structures were thus established.atography) on a TSK 2000SW column. (B) Separation of the insecticidal fraction II using
actions containing latartoxins are indicated.
Table 1
Molecular masses of latartoxins isolated from the venom of L. tarabaevi.
Peptide LtTx-1a LtTx-1b LtTx-2a LtTx-2b LtTx-2c
Molecular mass, Da 6569.7 6790.7 8333.8 7980.3 7669.1
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LtTx-2a, 2b, and 2c consist of 71, 67, and 65 amino acid residues, respec-
tively. The measured molecular masses of LtTx-2a, 2b and 2c and their
C-terminal fragments differed from the calculated values by ~1 Da. It
was concluded that these peptides are post-translationally modiﬁed
and contain amidated C-terminal residues.
Based on sequence similarity, latartoxins may be allocated to two
families, LtTx-1 (two members) and LtTx-2 (three members). Within
families, the peptides are very similar: LtTx-1a and b share 51% iden-
tity, whereas LtTx-2a–c share 63–88% identity. Between the families,
however, the similarity is rather low: 37% identical residues in
LtTx-1a and 2a. Only low sequence similarity is observed between
LtTx and other spider toxins (see below), we therefore conclude
that latartoxins form two novel families of toxins from spider venom.3.3. Venom gland cDNA database analysis
All determined amino acid sequences of LtTxwere comparedwith se-
quences from L. tarabaevi venom gland cDNA database (obtained in col-
laboration with DuPont Agriculture and Nutrition). As a result, cDNA
sequences coding for latartoxins were identiﬁed (Suppl. Figs. S1–S5),
and structures of LtTx protein precursors (pLtTx) were established
(Table 2).
Putative typical N-terminal signal (pre-) peptides of 19 residues
were identiﬁed using the SignalP 4.0 program (http://www.cbs.dtu.
dk/services/SignalP/) [14]. Signal peptides are quite similar both
within and across the LtTx families (58–74% and 47–58% identity, re-
spectively). Prosequences that are removed post-translationally fol-
low the prepeptides. In pLtTx-1 precursors these prosequences areFig. 2. Determination of latartoxin primary structures. Amino acid residues targeted during
sequencing using Edman degradation. Fragments released during toxin cleavage at speciﬁcvery short (6–7 residues), whereas in pLtTx-2 they are considerably
longer (18–24 residues) but also homologous (44–78% identity).
The propeptide cleavage occurs at a speciﬁc site known as the process-
ing quadruplet motif (PQM) common to precursors of spider toxins
[11,15]. The mature peptides correspond to the C-terminal parts of pre-
cursors. Moreover, pLtTx-2 have an additional C-terminal glycine. This
residue serves as a signal for C-terminal amidation of the peptides
[16] and provides further evidence in favor of the proposed modiﬁca-
tion of the mature peptides.3.4. Biological activity of latartoxins and LtTx-1a C-terminal fragment
Insecticidal activity of the crude venom and puriﬁed LtTx was test-
ed on ﬂesh ﬂy (S. carnaria) larvae and house crickets (A. domestica).
The median lethal dose (LD50) values determined for all native mole-
cules are typically ~50 μg/g (Table 3). At higher doses (~100 μg/g)
the toxins induced instant paralysis and death. Many other spider
toxins present similar activity, at least in the same order of magnitude
[17–20].
Paralytic activity of latartoxinswas investigated in the neuromuscu-
lar junction of C. vicina larvae. At concentration of 1 μM, both LtTx-1a
and LtTx-2a caused a decrease of the membrane potential (depolariza-
tion), eventually leading to muscle contraction, prominent increase of
the holding current, and decrease of the input resistance, indicating cy-
tolytic activity. The amplitude and frequency of spontaneous EPSCwere
not markedly affected. However, both toxins decreased the amplitude
of evoked EPSC, pointing to possible ion-channel-modulating activity.
We also inspected activity of the C-terminal fragment of LtTx-1a,
one of the most abundant L. tarabaevi toxins. A synthetic peptide
LtTx-1a C that corresponds to the 21 C-terminal residues of LtTx-1a
was produced using the conventional Fmoc/t-butyl chemistry. This pep-
tide did not show any insect toxicity up to the dose of ~200 μg/g.
LtTx-1a C was furthermore tested on a number of Gram-positive (A.
globiformis, B. subtilis) and Gram-negative (E. coli, P. aeruginosa) bacte-
ria. Two positive controls were used: we simultaneously tested the an-
timicrobial peptide latarcin 2a (Ltc 2a) from the same spider venomspeciﬁc polypeptide chain fragmentation are shown in boldface. Solid arrows indicate
bonds are indicated with dotted lines.
Table 2
LtTx precursor sequences (pLtTx) deduced from the cDNA of L. tarabaevi venom glands.
Different residues are shaded. Prosequences are aligned within the pLtTx families. The
processing quadruplet motif (PQM) is shown in boldface. See Fig. 2 for mature chain se-
quences. Three pLtTx (2a–2c) bear an additional C-terminal glycine residue that marks
the C-terminal amidation of the mature peptides (*).
Amino acid sequence
Name
Signal peptide Prosequence Mature chain
pLtTx-1a MKVLVFAIVCSVLLQVVLS AD-EEAR LtTx-1a
pLtTx-1b MKILVLAVVCTVLLQVALS ADSEEVR LtTx-1b
pLtTx-2a MKVLVIIALCLVAFQSALS -KKIENFESYIEDLKS-----EAR LtTx-2a*
pLtTx-2b MKVLVIIALCFFILQTALS EDKYESFESYVEDLKSGNMKGEAR LtTx-2b*
pLtTx-2c MKVLVITALCFILLQNVLG EDTYEDLQNYIENLINEN-QDEAR LtTx-2c*
Table 3
Insecticidal activities of puriﬁed LtTx and synthetic LtTx-1a C on ﬂesh ﬂy (S. carnaria)
larvae and house crickets (A. domestica).
Insect LD50 (μg/g)
LtTx-1a LtTx-1b LtTx-2a LtTx-2b LtTx-2c LtTx-1a C
S. carnaria 45 45 35 65 50 >170
A. domestica 50 45 30 60 50 >200
Table 4
Antimicrobial activity of LtTx-1a, synthetic LtTx-1a C, latarcin 2a and melittin (Melt).
Bacteria MIC, μM
LtTx-1a LtTx-1a C Ltc 2a Melt
A. globiformis Ac-1112 >20.0 3.1 0.6 0.3
B. subtilis B-501 >20.0 6.2 0.4 0.2
E. coli DH5α >20.0 >50.0 0.6 5.0
P. aeruginosa PAO1 >20.0 >50.0 6.2 10.0
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imal inhibitory concentrations (MICs) are listed in Table 4. LtTx-1a С
was active at micromolar concentrations on Gram-positive bacteria
only (MIC ~3–6 μM). The full-length toxin LtTx-1a showed no antimi-
crobial activity up to the concentration of 20 μM.Fig. 3. CD spectra. Spectra were recorded for the native full-length LtTx-1a3.5. CD spectra
We investigated the membrane-binding activity of full-length
LtTx-1a and LtTx-1a C using different techniques. CD spectroscopy
data showed that LtTx-1a C assumes a largely disordered structure in
phosphate buffer and adopts α-helical conformation in membrane-
mimicking environment, such as SDS micelles (Fig. 3, Table 5). A corre-
sponding increase in α-helix content was observed for the full-length
toxin LtTx-1a upon transfer from phosphate buffer to SDS micelle sus-
pension. LUVs (100 nm in diameter) composed of DOPE and DOPG
were aggregated after addition of the synthetic peptide precluding CD
measurements, but also testifying in favor of LtTx-1a C membrane-
binding activity.3.6. Interaction with lipid membranes
Native toxin LtTx-1a and synthetic peptide LtTx-1a C were studied
for interaction with GUVs (1000 nm in diameter) formed from DOPE/
DOPG (7:3, w/w) using the spin-down assay. Interaction of the cytolytic
peptide Ltc 2a from the venomof L. tarabaeviwith GUVswas used as the
positive control and purotoxin-1 (PT1) from the spider Geolycosa sp.
[22] was the negative control. The corresponding chromatograms are
presented in Fig. 4. It is seen that LtTx-1a, LtTx-1a C and Ltc 2a are de-
pleted from the solution after centrifugation of GUV suspensions, pro-
viding direct evidence of their membrane-binding activity. In contrast,
PT1 does not bind to GUVs and remains in the supernatant.4. Discussion
4.1. Latartoxins contain an N-terminal ICK motif and a C-terminal
amphiphilic tail
Both latartoxin families feature the same primary structure signa-
ture CX6CXnCCXnCXCXnCXC that contains the principal structural
motif (PSM) CX6CXnCC and the extra structural motif (ESM) CXCXnCXC
characteristic of spider neurotoxins [11] (Fig. 5). LtTx therefore belong
to the structural class 2 of spider toxins according to Kozlov and Grishin
[23]. This signature relates to the more general knottin or ICK motif
CX2–7CX3–11CX0–7CX1–17CX1–19C found in hundreds of peptides from
various sources [24]. LtTx are thought to assume the conventional ICK
fold most common to spider toxins [1].(A) and synthetic LtTx-1a C (B) in phosphate buffer and 25 mM SDS.
Table 5
CD spectroscopy data.
Peptide Solution Secondary structure content (%)
α-Helix β-Sheet β-Turn Random
LtTx-1a Phosphate buffer 4 38 22 36
25 mM SDS 17 30 21 32
LtTx-1a C Phosphate buffer 6 26 24 44
25 mM SDS 59 6 14 21
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ture is in position 39 in LtTx-1 and 42–44 in LtTx-2, which leaves ex-
tended C-terminal tails of 21 residues in LtTx-1 and 23–27 residues in
LtTx-2. These tails are devoid of cysteine residues (except for single
cysteines in LtTx-2a and b, see discussion below) and contain an ex-
cess of positive charge (from +3 to +6 at pH 7) (Table 6). Using
the conventional Garnier–Osguthorpe–Robson method [25] or other
easy-accessible tools for secondary structure predictions, this tail is pre-
dicted to adopt a largely α-helical conformation in all latartoxins. Plot-
ted as α-helices these peptide fragments reveal marked amphiphilicity
with hydrophilic and hydrophobic residues clustering on the opposite
sides of the cylinders (see Fig. 6 for LtTx-1a C-terminus). This is typical
for α-helical membrane-active peptides, including a great number of
well-studied AMPs and cytolytic toxins, such as melittin from the hon-
eybee [21] or latarcin 2a (Ltc 2a) from L. tarabaevi [10] (see Table 6 for
sequences and Fig. 6 for helical wheel projections). It is in the mem-
brane environment that amphiphilicity becomes crucial, the peptides
effectively localize to the membrane interface with hydrophobic parts
facing towards the membrane core and hydrophilic residues sticking
out towards the aqueous phase.4.2. The C-terminal tail of LtTx-1a is a membrane-active peptide
To explore its membrane activity, we chemically synthesized
LtTx-1a C. Indeed, in membrane-mimicking environment this peptide
assumedα-helical conformation, as shown by CD (Fig. 3, Table 5). The
membrane-binding activity of LtTx-1a C was visualized in the
spin-down assay (Fig. 4). Similar to Ltc 2a, the peptide interacts
with GUVs, whereas PT1 (an exemplary ICK spider toxin without
the C-terminal extension) does not. Moreover, LtTx-1a C possesses an-
timicrobial activity against certain Gram-positive bacteria, reminiscentFig. 4. Spin-down assay. Shown are HPLC proﬁles of aliquots of aqueous solutions remaining
tides get depleted from the solutions.of cationicα-helical AMPs (Table 4).We believe that the observed resis-
tance of Gram-negative bacteria is due to the outer membrane that ab-
sorbs most of the peptide and prevents its diffusion to the plasma
membrane. The same argumentation was used to explain speciﬁcity of
other AMPs [26].4.3. The C-terminal tail endows the full-length latartoxin with membrane
activity
Just like LtTx-1a C, α-helicity of LtTx-1a increases in membrane-
mimicking environment (Fig. 3, Table 5). This increase is due to the
C-terminal tail: ~60% α-helix in ~35% of the sequence length gives
~20% helicity of the full toxin, in good agreement with the experi-
mental data. LtTx-1a effectively interacts with GUVs (Fig. 4). The ab-
sence of antimicrobial activity in full-length LtTx may be explained
by an inhibitory role of the comparatively large ICK domain that ap-
parently decreases the membrane-lytic potential of the C-terminal
tail.
Curiously, within one of the latartoxin families, LtTx-2, we note in-
dications of the ongoing molecular evolution: a new ﬁfth disulﬁde
bridge (in LtTx-2a and b) has been grafted onto the four-disulﬁde
scaffold (as in LtTx-2c), thereby attaching the C-terminal tail to the
core of the molecule (Fig. 5). The essence of such an innovation is
not clear at this point.
The membrane-damaging activity of LtTx is corroborated by the
observed effects in ﬂy neuromuscular preparations. Latartoxins mark-
edly depolarize muscle membranes by increasing the conductance.
The effects are very similar to those reported for CpTx 1 from
Cheiracanthium punctorium, a two-domain cytolytic toxin [13] that
shows similar “molecular design” to LtTx (see below).4.4. Spider toxins across different families share the “ICK+α-helix”
design
Low but considerable similarity is found between LtTx and some
other spider toxins. LtTx-1a and CSTX-9 from the wandering spider
Cupiennius salei (Ctenidae) [20] have 45% identity, and related se-
quences for both LtTx families can be found in the transcriptome of
the wolf spider Lycosa singoriensis (Lycosidae) [27] (Fig. 7). The men-
tioned toxins are characterized by the same overall structural pattern:after centrifugation of the samples. In case of GUV suspensions, membrane-active pep-
Fig. 5. Amino acid sequences of LtTx. Identical residues are shaded gray, and cysteine residues are shaded black. Putative disulﬁde bridges are represented by black lines.
Table 6
Sequences of C-terminal linear parts of LtTx, latarcin 2a, and melittin. Positively
charged amino acid residues are in bold type. -NH2 designates C-terminal amidation.
Peptide C-terminal amino acid sequence Charge (pH 7)
LtTx-1a C -KKSLLAKAKNFGGKVITIFKA +5
LtTx-1b C -KKTLWQKTKDKLSTAGDILKS +3
LtTx-2a C -QRKETVESMMKCVRFVKKVGEKVIEKV-NH2 +4
LtTx-2b C -QRKETVENMMKCVRFVKKVVEKV-NH2 +4
LtTx-2c C -QRKETVEKMMKGMKYIKNLGKKI-NH2 +6
Ltc 2a GLFGKLIKKFGRKAISYAVKKARGKH +9
Melt GIGAILKVLSTGLPALISWIKRKRQQ-NH2 +6
730 A.I. Kuzmenkov et al. / Biochimica et Biophysica Acta 1828 (2013) 724–731an N-terminal ICK motif is followed by an extended amphiphilic
C-terminus with high α-helical propensity.
Although in this case sequence similarity is almost insigniﬁcant
(except for the cysteine motifs), other spider toxins share the same
“molecular design” containing two “modules”: an ICK domain followed
by a helix-forming tail. Among these are CSTX-1 [28] and CSTX-13 [29]
toxins from C. salei, LSTX toxins from L. singoriensis [27], and CpTx 1
from C. punctorium [13]. The latter toxin is a special case, since it repre-
sents a “dimer”molecule with two homologous ICK domains in a single
polypeptide chain; each domain is followed by a cysteine-free fragment
with high helix-forming propensity.
It seems to us that the described toxin architecture is quite wide-
spread among spiders due to its utility. It was found for CSTX-1, for
example, that the C-terminal segment is important for the high toxic-
ity and its trimming results in signiﬁcant decrease of insecticidal ac-
tivity [19]. For CpTx 1 it was supposed that the two helix-forming
modules act as membrane attachment devices eventually leading to
the observed cytolytic effects of the toxin [13].Fig. 6.Helical wheel projections for the C-terminal linear part of LtTx-1a (LtTx-1a C), latarcin
Hydrophobic residues are in black circles, positively charged residues are shaded gray, neu4.5. Latartoxins: membrane-dependent mode of action
The “ICK+α-helix”modular toxin architecture points to the probable
mode of action of these molecules. The C-terminal amphiphilic modules
seem to act as membrane-targeting or anchoring motifs. In this regard,
two major possibilities should be considered (see Graphical abstract).
One is that the toxins ﬁrst localize to the target cell membranes via
their C-terminal segments and then interact with cognate protein re-
ceptors (such as calcium channels in case of CSTX-1 [18]) using the
ICK domains following lateral diffusion. Indeed, the observed effect
on the membrane potential in ﬂy muscles is consistent with the
membrane activity of LtTx, whereas inhibition of EPSCs suggests the
presence of ion-channel-modulating activity. A similar mode of action
was earlier proposed for certain spider toxins affecting ion channels
and nick-named “membrane-access mechanism” [30]. Those typical
single-ICK-domain spider toxins are amphiphilic due to the presence
of hydrophobic residues in conserved positions of their sequences.
The other possibility is that latartoxins and similarly organized pep-
tides directly bind to their receptors and this interaction is further stabi-
lized by the membrane-anchoring activity of the C-terminal amphiphilic
α-helices that prevent toxin dissociation from the complex. Both scenar-
ios seem logical, and further research is needed to discriminate them. In
any case, the C-terminal segments seem to play a central role.
4.6. L. tarabaevi: an expert in membrane-active toxins
As outlined in the Introduction, most spiders studied to date produce
venom enriched in peptide neurotoxins, conferring to the general ICK
fold. Some spiders are known to produce cytolytic peptides in addition
to the ICK-containing neurotoxins. These are members of the Lycosoidea
superfamily: L. singoriensis [31], C. salei [32], and Oxyopes takobius
(Oxyopidae) [17]. In this respect, L. tarabaevi presents a unique venom2a (Ltc 2a) andmelittin (Melt). Amino acid sequences of the peptides are shown above.
tral polar and glycine residues are in white circles.
Fig. 7. Amino acid sequence alignment of LtTx with toxins from C. salei (CSTX) and L. singoriensis (LSTX). Identical residues are shaded gray, and cysteine residues are shaded black.
731A.I. Kuzmenkov et al. / Biochimica et Biophysica Acta 1828 (2013) 724–731composition. Two groups of peptides from this spider venom described
previously are the conventional short AMPs latarcins [10] and the excep-
tionally long “modular” cytolytic and insecticidal CITs [5]. Both groups are
devoid of cysteine residues. Here we studied a third well-presented
group of L. tarabaevi toxins, the ICK-containing latartoxins. Although
thesemolecules seem typical spider ICK toxins at ﬁrst sight, close inspec-
tion identiﬁes their membrane-active C-terminal extensions. Altogether,
the three groups amount to>50% of the crude venom.With this inmind,
we regard L. tarabaevi as a true “expert” in membrane-active toxins.
5. Accession numbers
The protein sequences of latartoxins (LtTx) reported in this paper
have been submitted to the UniProt Knowledgebase (UniProtKB)
under the accession numbers B3EWF2–B3EWF6. The nucleotide se-
quences encoding LtTx have been submitted to the GenBank under
the accession numbers JQ513641–JQ513647.
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Note added in proof
When this article had been reviewed, a paper by Kuhn-Nentwig et
al. came out (J. Biol. Chem. 287 (2012) 25640-25649) describing sim-
ilar logic applied to CSTX-1 from C. salei.
References
[1] A.A. Vassilevski, S.A. Kozlov, E.V. Grishin, Molecular diversity of spider venom,
Biochemistry (Moscow) 74 (2009) 1505–1534.
[2] L. Kuhn-Nentwig, R. Stöcklin, W. Nentwig, Venom composition and strategies in
spiders: is everything possible? Adv. Insect Physiol. 40 (2011) 1–86.
[3] P.H. da Silva, R.B. da Silveira, M.H. Appel, O.C. Mangili, W. Gremski, S.S. Veiga,
Brown spiders and loxoscelism, Toxicon 44 (2004) 693–709.
[4] E.V. Grishin, Black widow spider toxins: the present and the future, Toxicon 36
(1998) 1693–1701.
[5] A.A. Vassilevski, S.A. Kozlov, O.V. Samsonova, N.S. Egorova, D.V. Karpunin, K.A.
Pluzhnikov, A.V. Feofanov, E.V. Grishin, Cyto-insectotoxins, a novel class of cytolytic
and insecticidal peptides from spider venom, Biochem. J. 411 (2008) 687–696.
[6] E.V. Grishin, T.M. Volkova, A.S. Arseniev, Isolation and structure analysis of com-
ponents from venom of the spider Argiope lobata, Toxicon 27 (1989) 541–549.
[7] L. Kuhn-Nentwig, Antimicrobial and cytolytic peptides of venomous arthropods,
Cell. Mol. Life Sci. 60 (2003) 2651–2668.
[8] G. Estrada, E. Villegas, G. Corzo, Spider venoms: a rich source of acylpolyamines
and peptides as new leads for CNS drugs, Nat. Prod. Rep. 24 (2007) 145–161.[9] A.A. Vassilevski, S.A. Kozlov, T.A. Egorov, E.V. Grishin, Puriﬁcation and character-
ization of biologically active peptides from spider venoms, Methods Mol. Biol. 615
(2010) 87–100.
[10] S.A. Kozlov, A.A. Vassilevski, A.V. Feofanov, A.Y. Surovoy, D.V. Karpunin, E.V. Grishin,
Latarcins, antimicrobial and cytolytic peptides from the venomof the spider Lachesana
tarabaevi (Zodariidae) that exemplify biomolecular diversity, J. Biol. Chem. 281 (2006)
20983–20992.
[11] S. Kozlov, A. Malyavka, B. McCutchen, A. Lu, E. Schepers, R. Herrmann, E. Grishin,
A novel strategy for the identiﬁcation of toxinlike structures in spider venom,
Proteins 59 (2005) 131–140.
[12] S.W. Provencher, J. Glockner, Estimation of globular protein secondary structure
from circular dichroism, Biochemistry 20 (1981) 33–37.
[13] A.A. Vassilevski, I.M. Fedorova, E.E. Maleeva, Y.V. Korolkova, S.S. Eﬁmova, O.V.
Samsonova, L.V. Schagina, A.V. Feofanov, L.G.Magazanik, E.V. Grishin,Novel class of spi-
der toxin: active principle from the yellow sac spider Cheiracanthium punctorium
venom is a unique two-domain polypeptide, J. Biol. Chem. 285 (2010) 32293–32302.
[14] T.N. Petersen, S. Brunak, G. von Heijne, H. Nielsen, SignalP 4.0: discriminating sig-
nal peptides from transmembrane regions, Nat. Methods 8 (2011) 785–786.
[15] S.A. Kozlov, A.A. Vassilevski, E.V. Grishin, Secreted protein and peptide biosynthesis:
precursor structures and processing mechanisms, in: T.E. Esterhouse, L.B. Petrinos
(Eds.), Protein Biosynthesis, Nova Biomedical Books, New York, 2009, pp. 225–248.
[16] A.F. Bradbury, M.D. Finnie, D.G. Smyth, Mechanism of C-terminal amide forma-
tion by pituitary enzymes, Nature 298 (1982) 686–688.
[17] G. Corzo, E. Villegas, F. Gomez-Lagunas, L.D. Possani, O.S. Belokoneva, T. Nakajima,
Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider
Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity
with spider neurotoxins, J. Biol. Chem. 277 (2002) 23627–23637.
[18] H. Kubista, R.A. Mafra, Y. Chong, G.M. Nicholson, P.S. Beirao, J.S. Cruz, S. Boehm,W.
Nentwig, L. Kuhn-Nentwig, CSTX-1, a toxin from the venom of the hunting spider
Cupiennius salei, is a selective blocker of L-type calcium channels in mammalian
neurons, Neuropharmacology 52 (2007) 1650–1662.
[19] L. Kuhn-Nentwig, J. Schaller, U. Kampfer, H. Imboden, H. Malli, W. Nentwig, A ly-
sine rich C-terminal tail is directly involved in the toxicity of CSTX-1, a neurotoxic
peptide from the venom of the spider Cupiennius salei, Arch. Insect Biochem.
Physiol. 44 (2000) 101–111.
[20] J. Schalle, U. Kampfer, S. Schurch, L. Kuhn-Nentwig, S. Haeberli, W. Nentwig,
CSTX-9, a toxic peptide from the spider Cupiennius salei: amino acid sequence, di-
sulphide bridge pattern and comparison with other spider toxins containing the
cystine knot structure, Cell. Mol. Life Sci. 58 (2001) 1538–1545.
[21] H. Raghuraman, A. Chattopadhyay, Melittin: a membrane-active peptide with di-
verse functions, Biosci. Rep. 27 (2007) 189–223.
[22] E.V. Grishin, G.A. Savchenko, A.A. Vassilevski, Y.V. Korolkova, Y.A. Boychuk, V.Y.
Viatchenko-Karpinski, K.D. Nadezhdin, A.S. Arseniev, K.A. Pluzhnikov, V.B.
Kulyk, N.V. Voitenko, O.O. Krishtal, Novel peptide from spider venom inhibits
P2X3 receptors and inﬂammatory pain, Ann. Neurol. 67 (2010) 680–683.
[23] S. Kozlov, E. Grishin, Classiﬁcation of spider neurotoxins using structural motifs
by primary structure features. Single residue distribution analysis and pattern
analysis techniques, Toxicon 46 (2005) 672–686.
[24] J. Gracy, D. Le-Nguyen, J.C. Gelly, Q. Kaas, A. Heitz, L. Chiche, KNOTTIN: the knottin or
inhibitor cystine knot scaffold in 2007, Nucleic Acids Res. 36 (2008) D314–D319.
[25] J.F. Gibrat, J. Garnier, B. Robson, Further developments of protein secondary struc-
ture prediction using information theory. New parameters and consideration of
residue pairs, J. Mol. Biol. 198 (1987) 425–443.
[26] Y. Rosenfeld, D. Barra, M. Simmaco, Y. Shai, M.L. Mangoni, A synergism between
temporins toward Gram-negative bacteria overcomes resistance imposed by
the lipopolysaccharide protective layer, J. Biol. Chem. 281 (2006) 28565–28574.
[27] Y. Zhang, J. Chen, X. Tang, F. Wang, L. Jiang, X. Xiong, M. Wang, M. Rong, Z. Liu, S.
Liang, Transcriptome analysis of the venom glands of the Chinese wolf spider
Lycosa singoriensis, Zoology (Jena) 113 (2010) 10–18.
[28] L. Kuhn-Nentwig, J. Schaller, W. Nentwig, Puriﬁcation of toxic peptides and the
amino acid sequence of CSTX-1 from the multicomponent venom of Cupiennius
salei (Araneae:Ctenidae), Toxicon 32 (1994) 287–302.
[29] B. Wullschleger, L. Kuhn-Nentwig, J. Tromp, U. Kampfer, J. Schaller, S. Schurch, W.
Nentwig, CSTX-13, a highly synergistically acting two-chain neurotoxic enhancer
in the venom of the spider Cupiennius salei (Ctenidae), Proc. Natl. Acad. Sci. U. S. A.
101 (2004) 11251–11256.
[30] S.Y. Lee, R. MacKinnon, A membrane-access mechanism of ion channel inhibition
by voltage sensor toxins from spider venom, Nature 430 (2004) 232–235.
[31] B.A. Budnik, J.V. Olsen, T.A. Egorov, V.E. Anisimova, T.G. Galkina, A.K. Musolyamov,
E.V. Grishin, R.A. Zubarev, De novo sequencing of antimicrobial peptides isolated
from the venom glands of the wolf spider Lycosa singoriensis, J. Mass Spectrom. 39
(2004) 193–201.
[32] L. Kuhn-Nentwig, J. Muller, J. Schaller, A. Walz, M. Dathe, W. Nentwig, Cupiennin
1, a new family of highly basic antimicrobial peptides in the venom of the spider
Cupiennius salei (Ctenidae), J. Biol. Chem. 277 (2002) 11208–11216.
